These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 17045067)

  • 21. [Acarbose--an effective drug for the prevention of type 2 diabetes and cardiovascular diseases?].
    Laakso M
    Duodecim; 2003; 119(20):1921-3. PubMed ID: 14639996
    [No Abstract]   [Full Text] [Related]  

  • 22. [A search for novel pathways of effective prevention of cardiovascular complications in patients with type 2 diabetes mellitus: advance trial].
    Karpov IuA; Shubina AT
    Kardiologiia; 2007; 47(10):90-5. PubMed ID: 18260953
    [No Abstract]   [Full Text] [Related]  

  • 23. The changing spectrum of type 2 diabetes mellitus.
    Kayima JK
    East Afr Med J; 2002 Aug; 79(8):397-8. PubMed ID: 12638838
    [No Abstract]   [Full Text] [Related]  

  • 24. [The role of postprandial hyperglycemia in the development of cardiovascular diseases in type 2 diabetes mellitus].
    Shvarts V
    Klin Med (Mosk); 2009; 87(11):17-24. PubMed ID: 20143560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcomes trials and the cardiovascular effects of thiazolidinediones: implications for the evaluation of antidiabetic drugs.
    Gerstein HC; Yusuf S
    Am Heart J; 2010 Jul; 160(1):1-2. PubMed ID: 20598964
    [No Abstract]   [Full Text] [Related]  

  • 26. [Should we prescribe regular physical activity for patients presenting with type 2 diabetes?].
    Gautier JF
    Diabete Metab; 1994; 20(5):497-500. PubMed ID: 7859899
    [No Abstract]   [Full Text] [Related]  

  • 27. The metabolic syndrome, incidence of diabetes and mortality among the elderly: the Italian Longitudinal Study of Ageing.
    Noale M; Maggi S; Zanoni S; Limongi F; Zambon S; Crepaldi G;
    Diabetes Metab; 2012 Apr; 38(2):135-41. PubMed ID: 22071281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screen detected subjects with type 2 diabetes and impaired glucose tolerance have more adverse cardiovascular risk than subjects with impaired fasting glucose especially when they are obese: the ADDITION Netherlands study.
    Janssen PG; Gorter KJ; Stolk RP; Rutten GE
    Prim Care Diabetes; 2007 Jun; 1(2):69-74. PubMed ID: 18632022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility of childhood glucose homeostasis variables in predicting adult diabetes and related cardiometabolic risk factors: the Bogalusa Heart Study: comment on Nguyen et Al.
    d'Annunzio G; Russo C; Lorini R
    Diabetes Care; 2010 Sep; 33(9):e123; author reply e124. PubMed ID: 20805265
    [No Abstract]   [Full Text] [Related]  

  • 30. Dysglycaemia and risk of cardiovascular disease.
    Jarrett RJ
    Lancet; 1996 Jun; 347(9018):1833-4. PubMed ID: 8667944
    [No Abstract]   [Full Text] [Related]  

  • 31. Worldwide spread of lifestyle diseases and its importance for cardiovascular events.
    Erdmann E
    Drugs Today (Barc); 2006 Dec; 42 Suppl C():5-8. PubMed ID: 17245475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statins and risk of new-onset diabetes mellitus.
    Shah RV; Goldfine AB
    Circulation; 2012 Oct; 126(18):e282-4. PubMed ID: 23109518
    [No Abstract]   [Full Text] [Related]  

  • 33. Endothelial dysfunction plays a key role in increasing cardiovascular risk in type 2 diabetes: the Hoorn study.
    van Sloten TT; Henry RM; Dekker JM; Nijpels G; Unger T; Schram MT; Stehouwer CD
    Hypertension; 2014 Dec; 64(6):1299-305. PubMed ID: 25225211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The importance of tight blood glucose control in diabetes.
    Andersson DK
    Scand J Prim Health Care; 1995 Jun; 13(2):81-2. PubMed ID: 7569482
    [No Abstract]   [Full Text] [Related]  

  • 35. Management of T2DM in 2017: Clinically relevant results from cardiovascular outcome trials.
    Holman RR
    Nat Rev Endocrinol; 2018 Feb; 14(2):67-68. PubMed ID: 29302077
    [No Abstract]   [Full Text] [Related]  

  • 36. Cardiologist's role in improving glucose control and global cardiovascular risk in patients with type 2 diabetes mellitus.
    Gotto AM
    Am J Cardiol; 2007 Feb; 99(4A):3B-5B. PubMed ID: 17307053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dysglycaemia and risk of cardiovascular disease.
    Yudkin JS; Coppack S
    Lancet; 1996 Jun; 347(9018):1834. PubMed ID: 8667945
    [No Abstract]   [Full Text] [Related]  

  • 38. Summaries for patients. Are high sugar levels associated with new cardiovascular events in postmenopausal women who have already had a heart attack?
    Ann Intern Med; 2005 May; 142(10):I32. PubMed ID: 15897527
    [No Abstract]   [Full Text] [Related]  

  • 39. Novo Nordisk incretin and Cardiovascular Summit, Durban, June 2013.
    Wagenaar P
    Cardiovasc J Afr; 2013 Sep; 24(8):340. PubMed ID: 24240386
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardiovascular disease risk in youth with diabetes mellitus.
    Wadwa RP
    Rev Endocr Metab Disord; 2006 Sep; 7(3):197-204. PubMed ID: 17160723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.